跳至主要内容
临床试验/NCT01203241
NCT01203241已完成3 期

Benefit of Left Atrial Roof Ablation in Paroxysmal Atrial Fibrillation

Hospital Clinic of Barcelona2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
120
试验地点
2
主要终点
Freedom from atrial arrhythmias without antiarrhythmic drugs

研究概览

简要总结

The aim of the present study is to assess whether left atrial roof ablation adds any benefit in the arrhythmia-free probability after paroxysmal atrial fibrillation ablation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Drug-refractory paroxysmal atrial fibrillation

排除标准

  • Hypo or hyperthyroidism
  • Implantable defibrillation or pacemaker implanted
  • Moderate or severe mitral valve disease or mitral prosthetic valve
  • Ejection fraction less than 30%
  • Left atrial anteroposterior diameter more than 50 mm.
  • Previous atrial fibrillation ablation
  • Left atrium thrombus
  • Current infective disease or sepsis
  • Pregnant women
  • Current unstable angor
  • Acute myocardial infarction in last 3 months
  • Atrial fibrillation secondary to ionic disturbance, thyroids disease or secondary to any other reversible or non cardiovascular disease
  • Reduced expectancy of life (less than 12 months)
  • Patient participating in another clinical study that investigates a drug or device
  • Psychologically unstable patient or denies to give informed consent

结局指标

主要结局

Freedom from atrial arrhythmias without antiarrhythmic drugs

时间窗: 1-year follow-up

次要结局

  • Freedom from atrial arrhythmias with or without antiarrhythmic drugs(1-year follow-up)
  • Presence of any complications in the acute phase or during follow-up(1-year follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Josep Lluis Mont Girbau

Head of the Arrhythmia Unit

Hospital Clinic of Barcelona

研究点 (2)

Loading locations...

相似试验